These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Novel nanomicelle formulation to enhance bioavailability and stability of curcuminoids. Hatamipour M; Sahebkar A; Alavizadeh SH; Dorri M; Jaafari MR Iran J Basic Med Sci; 2019 Mar; 22(3):282-289. PubMed ID: 31156789 [TBL] [Abstract][Full Text] [Related]
24. Comparative Oral Absorption of Curcumin in a Natural Turmeric Matrix with Two Other Curcumin Formulations: An Open-label Parallel-arm Study. Gopi S; Jacob J; Varma K; Jude S; Amalraj A; Arundhathy CA; George R; Sreeraj TR; Divya C; Kunnumakkara AB; Stohs SJ Phytother Res; 2017 Dec; 31(12):1883-1891. PubMed ID: 29027274 [TBL] [Abstract][Full Text] [Related]
25. Quantification of curcumin, demethoxycurcumin, and bisdemethoxycurcumin in rodent brain by UHPLC/ESI-Q-TOF-MS/MS after intra-nasal administration of curcuminoids loaded PNIPAM nanoparticles. Ahmad N; Warsi MH; Iqbal Z; Samim M; Ahmad FJ Drug Test Anal; 2014 Mar; 6(3):257-67. PubMed ID: 23703969 [TBL] [Abstract][Full Text] [Related]
26. Comparison of antioxidant, anticholinesterase, and antidiabetic activities of three curcuminoids isolated from Curcuma longa L. Kalaycıoğlu Z; Gazioğlu I; Erim FB Nat Prod Res; 2017 Dec; 31(24):2914-2917. PubMed ID: 28287280 [TBL] [Abstract][Full Text] [Related]
27. Curcumin, demethoxycurcumin and bisdemethoxycurcumin differentially inhibit cancer cell invasion through the down-regulation of MMPs and uPA. Yodkeeree S; Chaiwangyen W; Garbisa S; Limtrakul P J Nutr Biochem; 2009 Feb; 20(2):87-95. PubMed ID: 18495463 [TBL] [Abstract][Full Text] [Related]
28. A combination index and glycoproteomics-based approach revealed synergistic anticancer effects of curcuminoids of turmeric against prostate cancer PC3 cells. Wei MM; Zhao SJ; Dong XM; Wang YJ; Fang C; Wu P; Song GQ; Gao JN; Huang ZH; Xie T; Zhou JL J Ethnopharmacol; 2021 Mar; 267():113467. PubMed ID: 33058923 [TBL] [Abstract][Full Text] [Related]
29. Sensitive analysis of curcuminoids via micellar electrokinetic chromatography with laser-induced native fluorescence detection and mixed micelles-induced fluorescence synergism. Wu C; Wang W; Quan F; Chen P; Qian J; Zhou L; Pu Q J Chromatogr A; 2018 Aug; 1564():207-213. PubMed ID: 29891402 [TBL] [Abstract][Full Text] [Related]
30. The degradation of curcuminoids in a human faecal fermentation model. Tan S; Calani L; Bresciani L; Dall'asta M; Faccini A; Augustin MA; Gras SL; Del Rio D Int J Food Sci Nutr; 2015; 66(7):790-6. PubMed ID: 26471074 [TBL] [Abstract][Full Text] [Related]
31. Stability studies of pure and mixture form of curcuminoids by reverse phase-HPLC method under various experimental stress conditions. Peram MR; Jalalpure SS; Palkar MB; Diwan PV Food Sci Biotechnol; 2017; 26(3):591-602. PubMed ID: 30263583 [TBL] [Abstract][Full Text] [Related]
32. The differential cellular uptake of curcuminoids in vitro depends dominantly on albumin interaction. Itaya M; Miyazawa T; Zingg JM; Eitsuka T; Azzi A; Meydani M; Miyazawa T; Nakagawa K Phytomedicine; 2019 Jun; 59():152902. PubMed ID: 30981184 [TBL] [Abstract][Full Text] [Related]
34. A Comparative Pharmacokinetic Assessment of a Novel Highly Bioavailable Curcumin Formulation with 95% Curcumin: A Randomized, Double-Blind, Crossover Study. Stohs SJ; Ji J; Bucci LR; Preuss HG J Am Coll Nutr; 2018 Jan; 37(1):51-59. PubMed ID: 29043927 [TBL] [Abstract][Full Text] [Related]
35. Natural derivatives of curcumin attenuate the Wnt/beta-catenin pathway through down-regulation of the transcriptional coactivator p300. Ryu MJ; Cho M; Song JY; Yun YS; Choi IW; Kim DE; Park BS; Oh S Biochem Biophys Res Commun; 2008 Dec; 377(4):1304-8. PubMed ID: 19000900 [TBL] [Abstract][Full Text] [Related]
36. Investigating the Neuroprotective Effects of Turmeric Extract: Structural Interactions of β-Amyloid Peptide with Single Curcuminoids. Randino R; Grimaldi M; Persico M; De Santis A; Cini E; Cabri W; Riva A; D'Errico G; Fattorusso C; D'Ursi AM; Rodriquez M Sci Rep; 2016 Dec; 6():38846. PubMed ID: 28004737 [TBL] [Abstract][Full Text] [Related]
37. PNIPAM nanoparticles for targeted and enhanced nose-to-brain delivery of curcuminoids: UPLC/ESI-Q-ToF-MS/MS-based pharmacokinetics and pharmacodynamic evaluation in cerebral ischemia model. Ahmad N; Ahmad I; Umar S; Iqbal Z; Samim M; Ahmad FJ Drug Deliv; 2016 Sep; 23(7):2095-2114. PubMed ID: 25237726 [TBL] [Abstract][Full Text] [Related]
38. The effects of tetrahydrocurcumin compared to curcuminoids on human platelet aggregation and blood coagulation in vitro. Chapman K; Scorgie FE; Ariyarajah A; Stephens E; Enjeti AK; Lincz LF Thromb Res; 2019 Jul; 179():28-30. PubMed ID: 31075698 [No Abstract] [Full Text] [Related]
39. Increased bioavailability of curcumin using a novel dispersion technology system (LipiSperse®). Briskey D; Sax A; Mallard AR; Rao A Eur J Nutr; 2019 Aug; 58(5):2087-2097. PubMed ID: 29974228 [TBL] [Abstract][Full Text] [Related]
40. Determination of oral bioavailability of curcuminoid dispersions and nanoemulsions prepared from Curcuma longa Linnaeus. Lu PS; Inbaraj BS; Chen BH J Sci Food Agric; 2018 Jan; 98(1):51-63. PubMed ID: 28516478 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]